Cancer Conference 2016
Friday, August 12, 2016, 6–8 p.m.
Hyatt Regency Monterey, Monterey, California
Conference and dinner: $50
Presentation by Alan Ashworth
Alan Ashworth, one of the world’s preeminent cancer scientists, will cover issues in cancer genetics including:
- Discovery of the BRCA 2 gene
- Current and future role of next-generation sequencing gene panels in clinical care
- Review of the new UCSF Center for BRCA Research
- Evolution of poly-ADP ribose polymerase (PARP) inhibitors
About the speaker
Alan Ashworth, PhD, FRS, is president of the UCSF Helen Diller Family Comprehensive Cancer Center and senior vice president for Cancer Services, UCSF. His major contribution to cancer research has been his work on genes involved in cancer risk. He was a central part of the team that in 1995 discovered the BRCA2 gene, which is linked to a heightened risk of some types of cancer. A decade later, Ashworth identified a way to exploit genetic weaknesses in cancer cells, including mutated BRCA2, leading to a new approach to cancer therapy.
Ashworth leads a premier program that combines basic and clinical research, epidemiology/cancer control, and patient care, with a strong emphasis on translational science that moves discoveries toward new therapies.